High-Throughput Opportunity MedioSeq enables conversion of qPCR panels to a consolidated NGS workflow, offering labs a pathway to significantly increase throughput and data generation while reducing space, personnel, instruments, and consumables. Target labs include pathogen testing facilities looking to scale testing capacity and reduce per-sample costs.

Broad Application Market Applications span human diagnostics, veterinary, agricultural, environmental, and food testing. This breadth suggests multiple industry verticals to target with a single scalable platform, expanding potential pilot and deployment opportunities beyond clinical labs.

Pandemic Track Record Medio Labs demonstrated capability by processing thousands of Covid-19 samples per day, signaling operational robustness and field-ready efficiency. Use this history to build credibility for capacity-focused sales conversations with labs facing surges or ongoing high-throughput needs.

Cost and Resource Efficiencies The platform promises reduced space, personnel, instruments, and consumables while increasing targets per panel and samples per run. Position as a capital-light, scalable solution ideal for mid-size to small labs seeking rapid ROI and flexible deployment.

Emerging Growth Focus Revenue is under one million with a small team, indicating a potential for strategic partnerships, pilot programs, or channel partnerships to accelerate commercialization. Engage with distributors, service labs, or CROs looking to expand NGS capabilities.